e-learning
resources
Munich 2006
Monday 04.09.2006
Smoking cessation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Projecting long term effects of tobacco control. The RIVM chronic disease model
P. H. M. van Baal, T. L. Feenstra, R. T. Hoogenveen, H. C. Boshuizen (Bilthoven, Netherlands)
Source:
Annual Congress 2006 - Smoking cessation
Session:
Smoking cessation
Session type:
Poster Discussion
Number:
2310
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. H. M. van Baal, T. L. Feenstra, R. T. Hoogenveen, H. C. Boshuizen (Bilthoven, Netherlands). Projecting long term effects of tobacco control. The RIVM chronic disease model. Eur Respir J 2006; 28: Suppl. 50, 2310
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Clinical phenotypes of severe asthma: adults
Results of Turkish smoking cessation polyclinics data’s analysis (TUSPA study)
Do e-cigarettes induce smoking cessation?
Related content which might interest you:
Assessment of variations in control of asthma over time
Source: Eur Respir J 2003; 22: 298-304
Year: 2003
Role of tobacco exposure in the course of COVID-19 disease and the impact of the disease on smoking behavior
Source: Virtual Congress 2021 – COVID - 19, smoking and e-cigarettes
Year: 2021
Is it possible to predict asthma outcomes? A disease model for economic analysis.
Source: International Congress 2017 – Asthma management
Year: 2017
Integrated disease management (IDM) intervention for COPD patients has long-term effects on patient activation
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016
Complexity in chronic asthma and COPD: implications for risk assessment, disease progression and control
Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium
Year: 2008
Present and future costs of COPD in Iceland and Norway: results from the BOLD study
Source: Eur Respir J 2009; 34: 850-857
Year: 2009
Projections of the future burden of COPD in the Netherlands by disease severity using a dynamic population model of disease progression
Source: Eur Respir J 2004; 24: Suppl. 48, 700s
Year: 2004
Late Breaking Abstract - The effect of comorbidity on the course and outcomes of COPD in observation in the primary health care, including on the background of the COVID-19 pandemic: a comparative analysis.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021
4–year trajectory of medication adherence amongst severe asthma patients: Risk factors and impact on asthma control
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
Prevention, socio-economic consequences and compensation issues
Source: Annual Congress 2005 - Occupational asthma
Year: 2005
Short and long term effects of PR. Can patients benefit of a short maintenance program?
Source: Annual Congress 2008 - Impact of rehabilitation programmes in COPD and non-COPD patients
Year: 2008
Are systemic manifestations ascribable to COPD in smokers? A structural equation modeling approach.
Source: International Congress 2014 – Passive smoking, active smoking and COPD
Year: 2014
Workplace smoking restriction and respiratory health: the Irish experience
Source: Annual Congress 2005 - Environmental tobacco smoke and obstructive lung disease
Year: 2005
The effects of clinically relevant reference agents in a mouse model of severe asthma
Source: International Congress 2015 – Advances in the future treatment of severe asthma
Year: 2015
Impact of smoke-free workplace legislation on exposures and health: possibilities for prevention
Source: Eur Respir J 2006; 28: 397-408
Year: 2006
Health status and chronic conditions in patients with COPD and their resident loved ones
Source: International Congress 2015 – Best abstracts on pulmonary rehabilitation in chronic lung diseases
Year: 2015
Health, social and economic consequences of chronic obstructive pulmonary disease (COPD): A controlled national study
Source: Annual Congress 2012 - Healthcare utilisation and treatment of asthma and COPD
Year: 2012
Does improvement in health status affect long term mortality in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 248s
Year: 2002
Impact and economic burden observed in asthma patients considered as mild: an analysis of the respiratory disease specific programme I
Source: Annual Congress 2003 - Burden of asthma
Year: 2003
The effect of regional differences on visual arts interpretation in exacerbation and stable periods of chronic airway diseases
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept